In the last trading session, 4.41 million shares of the RAPT Therapeutics Inc (NASDAQ:RAPT) were traded, and its beta was -0.11. Most recently the company’s share price was $1.23, and it changed around $0.37 or 43.34% from the last close, which brings the market valuation of the company to $162.72M. RAPT currently trades at a discount to its 52-week high of $4.74, offering almost -285.37% off that amount. The share price’s 52-week low was $0.71, which indicates that the current value has risen by an impressive 42.28% since then.
RAPT Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.67. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended RAPT as a Hold, whereas 1 deemed it a Buy, and 1 rated it as Underweight. RAPT Therapeutics Inc is expected to report earnings per share of -0.08 for the current quarter.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
Instantly RAPT has showed a green trend with a performance of 43.34% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.2350 on recent trading dayincreased the stock’s daily price by 0.4%. The company’s shares are currently down -22.15% year-to-date, but still up 46.69% over the last five days. On the other hand, RAPT Therapeutics Inc (NASDAQ:RAPT) is 40.67% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $33, which translates to bulls needing to increase their stock price by 96.27% from its current value. Analyst projections state that RAPT is forecast to be at a low of $2 and a high of $55.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.10%. RAPT Therapeutics Inc earnings are expected to increase by 89.04% in 2025, but the outlook is positive 48.05% per year for the next five years.
RAPT Dividends
RAPT Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 7.9972% or 3.11 million shares worth $9.48 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.05 shares worth $1.29 million, making up 0.79% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 744.95 shares worth around $0.92 million, which represents about 0.56% of the total shares outstanding.
